DEA

This Week In Cannabis: Rescheduling Delays, The DEA, Biden's Clemency, Philip Morris' New Bet And More
DEA Judge Cancels Marijuana Rescheduling Hearing Amid 'Disturbing' Allegations Of Improper Conduct
The Week In Cannabis: Tilray Earnings, NY Hits $1B In Sales, DoorDash Embraces Hemp, Ukraine And More
DEA Judge Cancels Marijuana Rescheduling Hearing Amid 'Disturbing' Allegations Of Improper Conduct
The Week In Cannabis: Tilray Earnings, NY Hits $1B In Sales, DoorDash Embraces Hemp, Ukraine And More
Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On

DEA Recent News

DEA's Cannabis Rescheduling Hearing Set To Begin In January 2025 As Controversy Mounts
DEA's cannabis rescheduling hearing begins January 21, 2025, as the industry raises concerns over process transparency and political influence.
Trump's DEA Drama: He Didn't Quit, I Fired Him — A Tale Of Pastors, Pandemic And Hurt Feelings
Florida's right-wing anti-maskers railed against Chronister during the Covid-19 pandemic. That may have cost him the DEA gig.
$13-Billion Drug War Funded By U.S. Taxpayers Fuels Violence In Developing Countries: New Report
U.S. taxpayer funding for drug war has led to human rights abuses and failed policies. Learn how foreign aid reinforces punitive drug control.
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.
Trump's DEA Pick Withdraws From Consideration, Will Keep Job As Florida Sheriff
Trump's DEA nominee, Florida sheriff Chad Chronister, has withdrawn from consideration after backlash. His office faced criticism over immigration policies.
Nebraska's Two-Front War On Cannabis
Nebraska: AG Mike Hilgers leads the fight against cannabis rescheduling, representing the state in the DEA hearing with prohibitionist SAM.
DEA LIVE Hearings On Marijuana Rescheduling, What To Expect
DEA's marijuana rescheduling hearings could reshape cannabis policy, easing research and tax rules while stopping short of full legalization.
Trump's Kash Patel FBI Pick And DEA Nominee Could Signal Shift In Drug Enforcement Priorities
Patel's vision for the FBI involves a sweeping restructuring, which includes dismantling its intelligence-gathering functions and purging its ranks of employees who are viewed as disloyal to Trump.
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.
Elon Musk, Vivek Ramaswamy: Here's An Agency You Might Want To Cut Back On And Save $40 Billion A Year
With Donald Trump's new DOGE initiative, it may be time to dismantle the DEA and legalize cannabis.
Prohibitionist Group Denies Collusion Allegations Ahead Of DEA Cannabis Rescheduling Hearing
SAM denies collusion with the DEA amid cannabis rescheduling hearing allegations, calling the claims baseless distractions from the issue's merits.
DEA Denies Allegations Of Colluding With Anti-Marijuana Group While Involved In Cannabis Rescheduling Process
DEA denies allegations of improper talks with an anti-marijuana group during rescheduling, treats claims as "gossip" and requesting dismissal
DEA Judge Blocks Researcher's Motion In Cannabis Rescheduling Case
DEA denies MedPharm's motion to join marijuana rescheduling hearing, raising concerns over exclusion and bias favoring prohibitionists.
DEA Banned From Random Airport Searches After Scathing Justice Department Report Uncovers Corruption
The DEA has been barred from conducting random searches of travelers' belongings at airports and transit hubs following a Justice Department investigation that exposed corrupt practices.
US Overdose Deaths Decline As Fentanyl Potency Weakens, Harm Reduction Expands
U.S. overdose deaths decline 14.5% in 2024, driven by weaker fentanyl potency, harm reduction efforts, and shifts in drug use behavior.
DEA Is Compromised, DOJ Should Replace It In Cannabis Rescheduling, Claims Joint Motion
Veterans Group Challenges DEA For Seat At Cannabis Debate Table
Texas Smoke Shop Owners Sue DEA Over 'Intimidation And Bullying' Tactics In Raid Of Legal Retail Store
Texas smoke shop owners are suing law enforcement after August raids, alleging rights violations and unlawful seizures.
House Democrats Urge DEA To Speed Up Cannabis Rescheduling
House Democrats urge the DEA to reschedule cannabis under federal law while hinting at possible future descheduling.
Meet The Man Serving A 40-Year Sentence For Non-Violent Cannabis Charges, Awaiting Pardon From Biden
Edwin Rubis, now 56, was 29 when the DEA arrested him and charged him. No drugs, guns or money were found in his possession.
Cannabis Experts Say Weed Reform Is A Race Against Time, Is The DEA Delaying Biden's Rescheduling Proposal?
While rescheduling could provide some immediate relief, particularly by eliminating the 280E tax burden, the path forward remains uncertain.
EXCLUSIVE: DEA Stalling Hinders Critical Clinical Trials For Debilitating Conditions, Says MMJ BioPharma CEO
MMJ BioPharma's lawsuit against the DEA delays vital cannabis research for MS and HD treatments. Could this legal battle reshape policy?
Will The DEA Complete Cannabis Rescheduling? Hear From Experts The Day After Harris-Trump Debate
If cannabis is reclassified, the industry could see tax reforms, research opportunities, and the development of new regulatory frameworks.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved